2m 2m 2m 2m 2m 2m 2m
ROIVANT SCIENCES (ROIV)
NASDAQ
$32.17+$0.91 (+2.93%)
Price as of Jun 23, 2026 6:50 PM EDT- $22.3BMarket Cap
- 171.74%1-Year Change
- BiotechnologyIndustry
ROIVANT SCIENCES (ROIV)
$32.17+$0.91 (+2.93%)
Annual
Quarterly
03/31/2026 | 03/31/2025 | 03/31/2024 | 03/31/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 8.3M -71.57% | 29.1M -76.72% | 124.8M +103.65% | 61.3M +10.84% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 668.8M +44.92% | 461.5M +22.55% | 376.6M +6.21% | 354.6M +541.32% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | 687.4M +14.48% | 600.5M N/A | |
Research and Development Expense | -681.8M +23.87% | -550.4M +9.70% | -501.7M -4.47% | -525.2M +8.73% | |
Depreciation and Amortization Expense | 3.3M -76.21% | 14.1M -36.15% | 22.0M +16.86% | 18.9M N/A | |
Total Operating Expenses | 1.3B +13.20% | 1.1B -7.18% | 1.2B -0.44% | 1.2B -12.11% | |
Operating Profit | -515.1M -48.66% | -1.0B -123.65% | 4.2B +460.92% | -1.2B -13.05% | |
Interest Income | 178.1M -31.07% | 258.4M +76.46% | 146.4M +354.96% | 32.2M +136.87% | |
Interest Expense | N/A N/A | N/A N/A | -34.8M +24.35% | -28.0M +297.22% | |
Interest Income and Expense and Net | 178.1M -31.07% | 258.4M +131.42% | 111.6M +2,548.17% | 4.2M +104.47% | |
Total Nonoperating Income and Expense | 4.0M +137.42% | -10.7M +76.07% | -6.1M -138.52% | 15.8M +560.20% | |
Income before Taxes | -264.6M -61.18% | -681.6M -116.02% | 4.3B +447.27% | -1.2B +32.59% | |
Income Taxes | 133.3M +176.77% | 48.2M +116.77% | 22.2M +328.21% | 5.2M +1,306.50% | |
Extraordinary Items | 17.1M N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -299.8M +74.30% | -172.0M -103.95% | 4.3B +531.00% | -1.0B +19.37% | |
Net Income from Continuing Operations Applicable to Common | -299.8M -45.01% | -545.2M -112.54% | 4.3B +487.06% | -1.1B +21.63% | |
Basic EPS and Net Income | -0.43 +79.17% | -0.24 -104.32% | 5.55 +490.85% | -1.42 +12.70% | |
Diluted EPS and Net Income | -0.54 +125.00% | -0.24 -104.59% | 5.23 +468.31% | -1.42 +12.70% | |
Basic Weighted Average Shares | 693.9M -4.35% | 725.4M -7.39% | 783.2M +9.88% | 712.8M +6.43% | |
Diluted Weighted Average Shares | 693.9M -4.35% | 725.4M -12.71% | 831.0M +16.59% | 712.8M +6.43% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.4B -47.73% | 2.7B -58.45% | 6.5B +289.77% | 1.7B -18.62% | |
Short-Term Investments | 2.9B +32.29% | 2.2B N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 4.3B -12.18% | 4.9B -25.23% | 6.5B +289.77% | 1.7B -18.62% | |
Total Current Assets | 5.2B +3.35% | 5.0B -25.73% | 6.7B +274.28% | 1.8B -16.21% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 12.0M -0.58% | 12.1M -36.74% | 19.1M -51.24% | 39.1M +50.88% | |
Total Long-Term Assets | 40.9M +24.52% | 32.9M -15.98% | 39.1M -20.96% | 49.5M +207.49% | |
Total Assets | 5.7B +5.00% | 5.4B -24.72% | 7.2B +202.25% | 2.4B -7.56% | |
Income Taxes Payable | 45.7M +10,882.93% | 416,000 -96.03% | 10.5M +1,831.55% | 542,000 N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | 12.0M -70.53% | 40.7M N/A | |
Total Current Liabilities | 281.2M +88.24% | 149.4M -43.99% | 266.8M -2.09% | 272.4M +47.77% | |
Total Long-Term Debt | N/A N/A | N/A N/A | 430.6M +14.67% | 375.5M +78.80% | |
Total Long-Term Liabilities | 70,000 +218.18% | 22,000 -99.39% | 3.6M -78.85% | 17.0M +108.14% | |
Total Liabilities | 416.3M +66.68% | 249.7M -67.73% | 774.0M -1.03% | 782.0M +49.33% | |
Retained Earnings | -501.8M -532.37% | 116.1M -79.86% | 576.2M +115.27% | -3.8B +36.51% | |
Total Stockholders Equity | 4.5B -3.42% | 4.7B -21.46% | 6.0B +415.53% | 1.2B -30.13% | |
Total Shares Outstanding | 720.4M +3.51% | 695.9M -13.73% | 806.7M +6.12% | 760.1M +9.38% | |
Cash Flow | |||||
Cash from Operating Activities | -750.3M -10.61% | -839.5M +9.69% | -765.3M -9.26% | -843.4M +24.44% | |
Capital Expenditures | 8.2M +78.50% | 4.6M +232.78% | 1.4M -89.11% | 12.7M -27.22% | |
Cash from Investing Activities | -682.3M -61.37% | -1.8B -133.94% | 5.2B +11,854.55% | -44.3M -114.60% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 134.2M +111.00% | -1.2B -390.87% | 419.4M -16.04% | 499.5M +62.80% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -6,235.69% +80.57% | -3,453.32% -201.59% | 3,399.19% +277.23% | -1,917.95% N/A | |
Return on Assets | -5.38% +97.98% | -2.72% -103.00% | 90.49% +323.06% | -40.57% N/A | |
Return on Equity | -6.51% +101.57% | -3.23% -102.64% | 122.05% +270.23% | -71.70% N/A | |
Revenue Growth | -71.57% -6.71% | -76.72% -174.02% | 103.65% +856.00% | 10.84% N/A | |
Current Ratio | 18.37 -45.10% | 33.47 +32.61% | 25.24 +282.27% | 6.60 N/A | |
Cash Ratio | 5.05 -72.23% | 18.17 -25.82% | 24.50 +298.08% | 6.15 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | 0.07 -79.36% | 0.36 N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 0.06 -64.81% | 0.17 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow